Christopher Viehbacher, the chief executive of Sanofi SA, has decided to move from Paris, France to Boston, Massachusetts, US, the home of the company’s biotechnology subsidiary Genzyme. The decision was first reported in Le Monde on 3 June and later confirmed by the company.
